Research Article
Role of High-Density Lipoprotein Cholesterol (HDL-C) as a Clinical Predictor of Decompensation in Patients with Chronic Liver Disease (CLD)
Figure 1
Association of HDL-C with decompensation events on follow-up in patients with CLD. (a) Comparison of mean HDL-C levels between patients with decompensation and those with stable decompensated disease. (b) Association of mg/dL with risk of decompensation events on follow-up. Abbreviations: CLD: chronic liver disease; HDL-C: high-density lipoprotein cholesterol.
(a) |
(b) |